MUTED expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.193500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.646810E-01
Normal-vs-Stage2
5.876000E-02
Normal-vs-Stage3
3.390300E-02
Normal-vs-Stage4
5.545400E-01
Stage1-vs-Stage2
7.044400E-01
Stage1-vs-Stage3
2.145200E-01
Stage1-vs-Stage4
4.875800E-01
Stage2-vs-Stage3
2.704600E-01
Stage2-vs-Stage4
2.253800E-01
Stage3-vs-Stage4
1.266180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.803600E-02
Normal-vs-AfricanAmerican
2.404200E-01
Normal-vs-Asian
4.766200E-02
Caucasian-vs-AfricanAmerican
3.749000E-01
Caucasian-vs-Asian
1.926410E-01
AfricanAmerican-vs-Asian
1.672630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.767800E-02
Normal-vs-Female
8.406200E-02
Male-vs-Female
5.499400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.356590E-01
Normal-vs-Age(41-60Yrs)
9.387800E-02
Normal-vs-Age(61-80Yrs)
3.141700E-02
Normal-vs-Age(81-100Yrs)
3.176000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.964200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.909800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.683800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.043800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.190600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.865800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.041960E-01
Normal-vs-Daily Drinker
1.797410E-03
Normal-vs-Weekly Drinker
9.489900E-02
Normal-vs-Occasional Drinker
8.015600E-02
Normal-vs-Social Drinker
1.238410E-01
Non Drinker-vs-Daily Drinker
1.023560E-01
Non Drinker-vs-Weekly Drinker
7.420400E-01
Non Drinker-vs-Occasional Drinker
7.309000E-01
Non Drinker-vs-Social Drinker
8.454600E-01
Daily Drinker-vs-Weekly Drinker
3.228200E-01
Daily Drinker-vs-Occasional Drinker
3.968100E-02
Daily Drinker-vs-Social Drinker
9.376300E-02
Weekly Drinker-vs-Occasional Drinker
5.254200E-01
Weekly Drinker-vs-Social Drinker
6.435800E-01
Occasional Drinker-vs-Social Drinker
9.078800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.552000E-02
Normal-vs-Grade 2
3.425500E-02
Normal-vs-Grade 3
4.256100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.299400E-01
Grade 1-vs-Grade 3
1.444990E-01
Grade 1-vs-Grade 4
8.552000E-02
Grade 2-vs-Grade 3
5.524200E-01
Grade 2-vs-Grade 4
3.425500E-02
Grade 3-vs-Grade 4
4.256100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.618200E-02
Normal-vs-NonDiabetic
2.974200E-02
Diabetic-vs-NonDiabetic
9.222400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.457300E-03
Normal-vs-NoPancreatitis
4.551800E-02
Pancreatitis-vs-NoPancreatitis
6.709700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.401800E-02
Normal-vs-N1
7.731700E-02
N0-vs-N1
5.087600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.443410E-01
Normal-vs-TP53-NonMutant
1.472980E-01
TP53-Mutant-vs-TP53-NonMutant
9.450000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
